BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:00 PM
 | 
Jul 22, 2009
 |  BC Extra  |  Top Story

Bristol-Myers to acquire Medarex

Bristol-Myers Squibb Co. (NYSE:BMY) said late Wednesday that it plans to acquire Medarex Inc. (NASDAQ:MEDX) in a tender offer of $16 per share, or about $2.4 billion in cash. Bristol-Myers said it expects Medarex to...

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >